skip to Main Content

Gen Magazine features Dr. Aaron Wheeler’s research in microfluidics

MI_kapplexGEN Magazine (Genetic Engineering and Biotechnology News) featured the microfluidics research of Dr. Aaron Wheeler on November 15, 2012.

Wheeler, Canada Research Chair of Bioanalytical Chemistry and an associate professor at the University of Toronto, has made an invention disclosure to MaRS Innovation; Kapplex is the start-up company created to commercialize his research.

Continue Reading

OICR and MaRS Innovation announce funding to develop Cellax™, a nanotechnology-based cancer drug

CellaxTORONTO, ON (November 13, 2012) — The Ontario Institute for Cancer Research (OICR) and MaRS Innovation (MI) today announced $1.5 million in funding from OICR over three years to further develop Cellax, a nanoparticle drug that could offer an alternative to chemotherapy with fewer side effects.

“Cellax is promising because it provides a more targeted strategy for treating tumours, killing tumour cells while minimizing the effect on healthy tissue,” said Dr. Rima Al-awar, director, OICR’s Medicinal Chemistry Platform. “OICR is proud to invest in a technology that has such potential to one day improve quality of life for cancer patients.”

Cellax, invented by Dr. Shyh-Dar Li and his research team in OICR’s Medicinal Chemistry Platform group, is a drug-polymer conjugate based on Dr. Li’s proprietary NanoCMC™ technology. These polymers self-assemble into defined nanoparticles and, when injected, selectively accumulate in tumours. Because of this property, the drug is released where it is most needed, increasing therapeutic benefits and reducing the side effects associated with conventional chemotherapy.

Continue Reading

Stem Cell Therapeutics, UHN and MaRS Innovation Announce Novel, Clinical-Stage, Cancer Stem Cell Program Agreement

Stem Cell Therapeutics Corp. logo
Stem Cell Therapeutics Corp.

Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a life sciences company developing stem cell-related technologies, today announced the signing of an agreement with University Health Network (UHN), through its commercialization agent MaRS Innovation (MI), both of Toronto.

The agreement provides Stem Cell Therapeutics (“SCT”) with an option to an exclusive world-wide license to an innovative cancer stem cell program.

This agreement produced a license for a UHN technology on April 17, 2013.

Continue Reading

Yonge Street Media covers Bedside Clinical Systems’ launch

Yonge Street Media, a weekly online magazine that covers talent, innovation, diversity and quality of life stories in the Toronto region, covered Bedside Clinical Systems’ (BCS) launch in their Innovation section on Wednesday, November 7, 2012.

BCS is a MaRS Innovation spin-off company created to commercialize decision-support research emerging from The Hospital for Sick Children (SickKids).

Continue Reading

Shotlst CEO featured in Globe article on future of tech in education

Shotlst LogoMatt Ratto, assistant professor in the University of Toronto’s Faculty of Information and co-inventor and CEO of Shotlst, a UTEST company, was featured in the Globe and Mail on October 22 in an article by Nick Rockel on how emerging technology will change the education experience.

Here’s an excerpt:

Asked what the technological tools in university classrooms will look and feel like by 2020, Matt Ratto admits he’s no futurist. But the assistant professor at the University of Toronto’s Faculty of Information is helping shape the future – by changing students’ relationship with technology.

Continue Reading

ClevrU partners with Schulich School of Business professors to target online education market

MaRS Innovation and York University’s commercialization office support new partnership

Students in China interact with the ClevrU platform
Students in China interact with the ClevrU platform. Photo courtesy of ClevrU Inc.

In the age of ITunes, videotaping lectures or converting existing textbooks into e-books won’t make you the market leader in online education.

Thanks to a new partnership between ClevrU, and NewMindsets Inc., facilitated by MaRS Innovation and York University’s commercialization office, Canadian technology and content promises to establish the second-generation online learning standard for millions of students worldwide.

Continue Reading

U of T, MaRS Innovation Collaborate to Launch Incubator for Student Software Companies

Hadi Aladdin (left) and Marwan Aladdin, U of T graduates and the founders of CoursePeer.
Hadi Aladdin (left) and Marwan Aladdin, U of T graduates and the founders of CoursePeer, one of six UTEST companies.

TORONTO, ON – A new program that provides nascent software companies with start-up funds, work space, mentoring and business strategy support, was launched today by the University of Toronto and commercialization partner MaRS Innovation, with support from the MaRS Discovery District.

TechVibes has a profile page for UTEST and covered CoursePeer as part of their students start-ups series.

The new program, called University of Toronto Early Stage Technology (UTEST), is part of a growing ecosystem of incubators and commercialization support services at U of T, including the newly-launched Banting and Best Institute. UTEST is unique among campus incubators in that its companies receive start-up funds—$30,000 each in this inaugural year—and because it accepts companies in the very earliest stages of idea generation, before they’re ready for traditional incubators.

Continue Reading
Back To Top